Latin America Allergy Diagnostics And Therapeutics Market Size & Outlook
The allergy diagnostics and therapeutics market in Latin America is expected to reach a projected revenue of US$ 3,453.3 million by 2033. A compound annual growth rate of 5.5% is expected of Latin America allergy diagnostics and therapeutics market from 2026 to 2033.
Pharmaceuticals
Respiratory Drugs
Allergy Diagnostics And Therapeutics Market Outlook
Latin America allergy diagnostics and therapeutics market highlights
The Latin America allergy diagnostics and therapeutics market generated a revenue of USD 2,232.4 million in 2025.
The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.
In terms of segment, therapeutics was the largest revenue generating type in 2025.
Diagnostics is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 2,232.4 million
Market revenue in 2033
USD 3,453.3 million
Growth rate
5.5% (CAGR from 2026 to 2033)
Largest segment
Therapeutics
Fastest growing segment
Diagnostics
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Diagnostics, Therapeutics
Key market players worldwide
Rohm Co Ltd, Thermo Fisher Scientific Inc, PerkinElmer, BioMerieux SA, Siemens Healthineers AG ADR, Omega Healthcare Investors Inc, Danaher Corp, Alcon Inc, AbbVie Inc, Sanofi SA, Allergy Therapeutics PLC, Pfizer Inc, Teva Pharmaceutical Industries Ltd, GSK PLC, Sun Pharmaceutical Industries, Roche Holding AG, Merck & Co Inc, Astellas Pharma Inc, Epigenomics AG
Other key industry trends
In terms of revenue, Latin America region accounted for 6.3% of the global allergy diagnostics and therapeutics market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 11,328.6 million by 2033.
Latin America region includes rapidly evolving economies, including Brazil and Mexico. Increasing R&D activities, coupled with rapid technological advancements in the region, are anticipated to fuel market growth.
Increasing government spending, growing investments by major pharmaceutical & biopharmaceutical companies, and presence of major academic research institutes are among the factors likely to promote market growth. Rising incidence of allergies such as asthma, allergic rhinitis, and food allergies.
However, most patients do not receive proper medication due to a lack of awareness, which may hinder market growth in the coming years. Similarly, other factors such as poor infrastructure combined with inaccessibility to remote regions, low affordability, and shortage of skilled professionals may hamper the market growth in this region during the forecast period.
Latin America Allergy Diagnostics And Therapeutics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Allergy Diagnostics And Therapeutics Market Outlook will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 92.55% in 2025.
Horizon Databook has segmented the Latin America allergy diagnostics and therapeutics market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
Latin America region includes rapidly evolving economies, including Brazil and Mexico. Increasing R&D activities, coupled with rapid technological advancements in the region, are anticipated to fuel market growth.
Increasing government spending, growing investments by major pharmaceutical & biopharmaceutical companies, and presence of major academic research institutes are among the factors likely to promote market growth. Rising incidence of allergies such as asthma, allergic rhinitis, and food allergies.
However, most patients do not receive proper medication due to a lack of awareness, which may hinder market growth in the coming years. Similarly, other factors such as poor infrastructure combined with inaccessibility to remote regions, low affordability, and shortage of skilled professionals may hamper the market growth in this region during the forecast period.
Latin America Allergy Diagnostics And Therapeutics Market Type Outlook (Revenue, USD Million , 2021-2033)
Diagnostics
Therapeutics
Latin America Allergy Diagnostics And Therapeutics Market Allergen Type Outlook (Revenue, USD Million , 2021-2033)
Food
Inhaled
Drug
Other Allergens
Reasons to subscribe to Allergy Diagnostics And Therapeutics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Allergy Diagnostics And Therapeutics Market Outlook databook
Our clientele includes a mix of Allergy Diagnostics And Therapeutics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Allergy Diagnostics And Therapeutics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Allergy Diagnostics And Therapeutics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Allergy Diagnostics And Therapeutics Market, 2021-2033 (US$M)